Evaluation of Human Papilloma Virus Diagnostic Testing in Oropharyngeal Squamous Cell Carcinoma: Sensitivity, Specificity, and Prognostic Discrimination



Schache, Andrew G ORCID: 0000-0001-9466-6038, Liloglou, Triantafilos ORCID: 0000-0003-0460-1404, Risk, Janet M ORCID: 0000-0002-8770-7783, Filia, Anastasia, Jones, Terence M, Sheard, Jon, Woolgar, Julia A, Helliwell, Timothy R ORCID: 0000-0003-2112-4128, Triantafyllou, Asterios, Robinson, Max
et al (show 4 more authors) (2011) Evaluation of Human Papilloma Virus Diagnostic Testing in Oropharyngeal Squamous Cell Carcinoma: Sensitivity, Specificity, and Prognostic Discrimination. Clinical Cancer Research, 17 (19). pp. 6262-6271.

[img] PDF
Schache_accepted_version.pdf - Author Accepted Manuscript

Download (1MB)

Abstract

<jats:title>Abstract</jats:title> <jats:p>Purpose: Human papillomavirus-16 (HPV16) is the causative agent in a biologically distinct subset of oropharyngeal squamous cell carcinoma (OPSCC) with highly favorable prognosis. In clinical trials, HPV16 status is an essential inclusion or stratification parameter, highlighting the importance of accurate testing.</jats:p> <jats:p>Experimental Design: Fixed and fresh-frozen tissue from 108 OPSCC cases were subject to eight possible assay/assay combinations: p16 immunohistochemistry (p16 IHC); in situ hybridization for high-risk HPV (HR HPV ISH); quantitative PCR (qPCR) for both viral E6 RNA (RNA qPCR) and DNA (DNA qPCR); and combinations of the above.</jats:p> <jats:p>Results: HPV16-positive OPSCC presented in younger patients (mean 7.5 years younger, P = 0.003) who smoked less than HPV-negative patients (P = 0.007). The proportion of HPV16-positive cases increased from 15% to 57% (P = 0.001) between 1988 and 2009. A combination of p16 IHC/DNA qPCR showed acceptable sensitivity (97%) and specificity (94%) compared with the RNA qPCR “gold standard”, as well as being the best discriminator of favorable outcome (overall survival P = 0.002). p16 IHC/HR HPV ISH also had acceptable specificity (90%) but the substantial reduction in its sensitivity (88%) impacted upon its prognostic value (P = 0.02). p16 IHC, HR HPV ISH, or DNA qPCR was not sufficiently specific to recommend in clinical trials when used in isolation.</jats:p> <jats:p>Conclusions: Caution must be exercised in applying HPV16 diagnostic tests because of significant disparities in accuracy and prognostic value in previously published techniques. Clin Cancer Res; 17(19); 6262–71. ©2011 AACR.</jats:p>

Item Type: Article
Additional Information: ## TULIP Type: Articles/Papers (Journal) ## issn: 21969383
Uncontrolled Keywords: HPV, oropharyngeal, SCC, diagnosis, prognosis
Subjects: ?? RK ??
Divisions: Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences > School of Dentistry
Depositing User: Symplectic Admin
Date Deposited: 12 Oct 2011 16:41
Last Modified: 16 Dec 2022 04:36
DOI: 10.1158/1078-0432.ccr-11-0388
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3893